During the past decade, Novant Health Heart and Vascular Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novant Health Heart and Vascular Institute" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Duke University" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Heart and Vascular Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "American Physical Therapy Association" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Heart and Vascular Institute" are "Heart Failure" (7 trials), "Coronary Artery Disease" (4 trials), "Cardiovascular Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Novant Health Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Novant Health Heart and Vascular Institute" are "Device" (19 trials), "Drug" (15 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Anti-coagulation therapy" (1 trials) and "Anti-platelet therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Heart and Vascular Institute" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Novant Health Heart and Vascular Institute". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Novant Health Heart and Vascular Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".